MedCity News sat down with John Coleman, Business Unit Director at YSDS Life Science, to talk about the challenges of delivering temperature-sensitive goods and how to overcome them.
OrbiMed has closed its largest venture capital healthcare fund to date as two partners predict a resurgence in biotech investment next year. The robust reception biotech initial public offerings have received this year is fueling this trend, according to Jonathan Silverstein, a general partner and co-head of global private equity at the firm. The $735 […]
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.